Advertisement
Home »

High-Throughput Drug Screen for Potential Combinations With Venetoclax Guides the Treatment of Transformed Follicular Lymphoma.

Jun 05, 2023

ABOUT THE EXPERTS

  • Zhifeng Li

    The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.

    Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China.

    Key laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China.

    Guangchao Pan

    Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China.

    Key laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China.

    Mengya Zhong

    Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China.

    Key laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China.

    Li Zhang

    Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China.

    Key laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China.

    Xingxing Yu

    Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China.

    Key laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China.

    Jie Zha

    Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China.

    Key laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China.

    Bing Xu

    The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.

    Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China.

    Key laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement